Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Do, R; Willer, CJ; Schmidt, EM; Sengupta, S; Gao, C; Peloso, GM; Gustafsson, S; Kanoni, S; Ganna, A; Chen, J; Buchkovich, ML; Mora, S; Beckmann, JS; Bragg-Gresham, JL; Chang, HY; Demirkan, A; Den Hertog, HM; Donnelly, LA; Ehret, GB; Esko, T; Feitosa, MF; Ferreira, T; Fischer, K; Fontanillas, P; Fraser, RM; Freitag, DF; Gurdasani, D; Heikkilä, K; Hyppönen, E; Isaacs, A; Jackson, AU; Johansson, A; Johnson, T; Kaakinen, M; Kettunen, J; Kleber, ME; Li, X; Luan, J; Lyytikäinen, LP; Magnusson, PK; Mangino, M; Mihailov, E; Montasser, ME; Müller-Nurasyid, M; Nolte, IM; O'Connell, JR; Palmer, CD; Perola, M; Petersen, AK; Sanna, S; Saxena, R; Service, SK; Shah, S; Shungin, D; Sidore, C; Song, C; Strawbridge, RJ; Surakka, I; Tanaka, T; Teslovich, TM; Thorleifsson, G; Van den Herik, EG; Voight, BF; Volcik, KA; Waite, LL; Wong, A; Wu, Y; Zhang, W; Absher, D; Asiki, G; Barroso, I; Been, LF; Bolton, JL; Bonnycastle, LL; Brambilla, P; Burnett, MS; Cesana, G; Dimitriou, M; Doney, AS; Döring, A; Elliott, P; Epstein, SE; Eyjolfsson, GI; Gigante, B; Goodarzi, MO; Grallert, H; Gravito, ML; Groves, CJ; Hallmans, G; Hartikainen, AL; Hayward, C; Hernandez, D; Hicks, AA; Holm, H; Hung, YJ; Illig, T; Jones, MR; Kaleebu, P; Kastelein, JJ; Khaw, KT; Kim, E; Klopp, N; Komulainen, P; Kumari, M; Langenberg, C; Lehtimäki, T; Lin, SY; Lindström, J; Loos, RJ; Mach, F; McArdle, WL; Meisinger, C; Mitchell, BD; Müller, G; Nagaraja, R; Narisu, N; Nieminen, TV; Nsubuga, RN; Olafsson, I; Ong, KK; Palotie, A; Papamarkou, T; Pomilla, C; Pouta, A; Rader, DJ; Reilly, MP; Ridker, PM; Rivadeneira, F; Rudan, I; Ruokonen, A; Samani, N; Scharnagl, H; Seeley, J; Silander, K; Stančáková, A; Stirrups, K; Swift, AJ; Tiret, L; Uitterlinden, AG; van Pelt, LJ; Vedantam, S; Wainwright, N; Wijmenga, C; Wild, SH; Willemsen, G; Wilsgaard, T; Wilson, JF; Young, EH; Zhao, JH; Adair, LS; Arveiler, D; Assimes, TL; Bandinelli, S; Bennett, F; Bochud, M; Boehm, BO; Boomsma, DI; Borecki, IB; Bornstein, SR; Bovet, P; Burnier, M; Campbell, H; Chakravarti, A; Chambers, JC; Chen, YD; Collins, FS; Cooper, RS; Danesh, J; Dedoussis, G; de Faire, U; Feranil, AB; Ferrières, J; Ferrucci, L; Freimer, NB; Gieger, C; Groop, LC; Gudnason, V; Gyllensten, U; Hamsten, A; Harris, TB; Hingorani, A; Hirschhorn, JN; Hofman, A; Hovingh, GK; Hsiung, CA; Humphries, SE; Hunt, SC; Hveem, K; Iribarren, C; Järvelin, MR; Jula, A; Kähönen, M; Kaprio, J; Kesäniemi, A; Kivimaki, M; Kooner, JS; Koudstaal, PJ; Krauss, RM; Kuh, D; Kuusisto, J; Kyvik, KO; Laakso, M; Lakka, TA; Lind, L; Lindgren, CM; Martin, NG; März, W; McCarthy, MI; McKenzie, CA; Meneton, P; Metspalu, A; Moilanen, L; Morris, AD; Munroe, PB; Njølstad, I; Pedersen, NL; Power, C; Pramstaller, PP; Price, JF; Psaty, BM; Quertermous, T; Rauramaa, R; Saleheen, D; Salomaa, V; Sanghera, DK; Saramies, J; Schwarz, PE; Sheu, WH; Shuldiner, AR; Siegbahn, A; Spector, TD; Stefansson, K; Strachan, DP; Tayo, BO; Tremoli, E; Tuomilehto, J; Uusitupa, M; van Duijn, CM; Vollenweider, P; Wallentin, L; Wareham, NJ; Whitfield, JB; Wolffenbuttel, BH; Altshuler, D; Ordovas, JM; Boerwinkle, E; Palmer, CN; Thorsteinsdottir, U; Chasman, DI; Rotter, JI; Franks, PW; Ripatti, S; Cupples, LA; Sandhu, MS; Rich, SS; Boehnke, M; Deloukas, P; Mohlke, KL; Ingelsson, E; Abecasis, GR; Daly, MJ; Neale, BM; Kathiresan, S.
Common variants associated with plasma triglycerides and risk for coronary artery disease.
Nat Genet. 2013; 45(11):1345-1352 Doi: 10.1038/ng.2795 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz
März Winfried
Scharnagl Hubert
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Triglycerides are transported in plasma by specific triglyceride-rich lipoproteins; in epidemiological studies, increased triglyceride levels correlate with higher risk for coronary artery disease (CAD). However, it is unclear whether this association reflects causal processes. We used 185 common variants recently mapped for plasma lipids (P < 5 × 10(-8) for each) to examine the role of triglycerides in risk for CAD. First, we highlight loci associated with both low-density lipoprotein cholesterol (LDL-C) and triglyceride levels, and we show that the direction and magnitude of the associations with both traits are factors in determining CAD risk. Second, we consider loci with only a strong association with triglycerides and show that these loci are also associated with CAD. Finally, in a model accounting for effects on LDL-C and/or high-density lipoprotein cholesterol (HDL-C) levels, the strength of a polymorphism's effect on triglyceride levels is correlated with the magnitude of its effect on CAD risk. These results suggest that triglyceride-rich lipoproteins causally influence risk for CAD.
Find related publications in this database (using NLM MeSH Indexing)
Biological Transport -
Cholesterol, HDL - blood
Cholesterol, LDL - blood
Coronary Artery Disease - blood
Humans -
Polymorphism, Single Nucleotide -
Risk Factors -
Triglycerides - blood

© Med Uni Graz • Impressum